Phage Therapy Experience at the Eliava Institute

Overview

Journal Med Mal Infect

Publisher Elsevier

Specialties General Medicine
Infectious Diseases

Date 2008 Aug 9

PMID 18687542

Citations 105

Authors

M Kutateladze

R Adamia

Affiliations

Soon will be listed here.

Abstract

The rapid spread of multidrug resistant bacterial strains limits the effectiveness of antibiotic treatments and induces intense research for alternatives. Today, the use of phage preparations as alternative approach is gaining attention, particularly for treating a wide variety of diseases which are difficult to control by chemotherapeutic agents. This article relates the phage therapy experience of the Eliava Institute of Bacteriophage, Microbiology and Virology.

Citing Articles

Bacteriophage therapy for multidrug-resistant infections: current technologies and therapeutic approaches.

Kim M, Suh G, Cullen G, Perez Rodriguez S, Dharmaraj T, Chang T J Clin Invest. 2025; 135(5).

PMID: 40026251 PMC: 11870740. DOI: 10.1172/JCI187996.

Phage therapy could be key to conquering persistent bacterial lung infections in children.

Sithu Shein A, Hongsing P, Khatib A, Phattharapornjaroen P, Miyanaga K, Cui L NPJ Antimicrob Resist. 2025; 2(1):31.

PMID: 39843534 PMC: 11721074. DOI: 10.1038/s44259-024-00045-4.

Sxt1, Isolated from a Therapeutic Phage Cocktail, Is a Broader Host Range Relative of the Phage T3.

Iarema P, Kotovskaya O, Skutel M, Drobiazko A, Moiseenko A, Sokolova O Viruses. 2025; 16(12.

PMID: 39772213 PMC: 11680406. DOI: 10.3390/v16121905.

In Vitro Susceptibility of Clinical and Carrier Strains of to STAFAL Phage Preparation.

Straka M, Hubenakova Z, Janosikova L, Bugalova A, Minich A, Wawruch M Int J Mol Sci. 2024; 25(23).

PMID: 39684595 PMC: 11641142. DOI: 10.3390/ijms252312885.

Efficacy of Bacteriophages in Wound Healing: An Updated Review.

Narayanan M, Kumar A, Verma G, Bairwa A, Mirza A, Goyal B Cureus. 2024; 16(10):e71542.

PMID: 39544596 PMC: 11563050. DOI: 10.7759/cureus.71542.